Literature DB >> 10100989

alpha-smooth-muscle actin and microvascular precursor smooth-muscle cells in pulmonary hypertension.

R Jones1, M Jacobson, W Steudel.   

Abstract

Little is known of the molecular basis of smooth-muscle cell development in the microvessels of the adult lung in pulmonary hypertension (PH). Using quantitative and immunogold electron microscopy techniques we report the development of microvascular precursor smooth-muscle cells (PSMCs) expressing alpha-smooth-muscle actin (alphaSMA), a first marker of smooth-muscle cell differentiation, in rats with hyperoxic PH. Increase in the frequency of distal (alveolar wall) vessels with alphaSMA cells preceded (Pchi2 < 0.02, Day 4) the increase in proximal (alveolar duct) vessels (Pchi2 < 0.02, Day 14). The smallest vessel with cells expressing alphaSMA (< 50 micrometer in diameter) increased most with time (Pchi2 < 0.001). Immunopositive PSMCs were rare in normal lung and frequent in hyperoxia. Well-developed filament arrays decorated with alphaSMA were detected in intermediate cells early in hyperoxia (Day 4). Similar filament networks were detected later in fibroblasts recruited to vessel walls (Days 7 to 14). By Day 28, cells derived from fibroblasts formed several layers in the vessel wall and expressed dense alphaSMA filament arrays, in either a central domain or mesh. Thus, intermediate cells are the source of cells expressing alphaSMA early in the microvessels in hyperoxic pulmonary hypertension and fibroblasts of cells in the late stage-the time of intense neomuscularization of the microvessels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100989     DOI: 10.1165/ajrcmb.20.4.3357

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  16 in total

1.  A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents.

Authors:  Rosemary C Jones; Diane E Capen; Kenneth S Cohen; Lance L Munn; Rakesh K Jain; Dan G Duda
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  A protocol for a lung neovascularization model in rodents.

Authors:  Rosemary C Jones; Diane Capen; Bodil Petersen; Rakesh K Jain; Dan G Duda
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 3.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

4.  Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.

Authors:  Jahidur Rashid; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-11       Impact factor: 5.464

Review 5.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

6.  Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.

Authors:  Chrystelle V Garat; Joseph T Crossno; Timothy M Sullivan; Jane E B Reusch; Dwight J Klemm
Journal:  J Cardiovasc Pharmacol       Date:  2010-05       Impact factor: 3.105

7.  Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.

Authors:  Jahidur Rashid; Kamrun Nahar; Snehal Raut; Ali Keshavarz; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2018-03-26       Impact factor: 4.939

8.  Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.

Authors:  Arkadi Beloiartsev; Maria da Glória Rodrigues-Machado; Guo Ling Zhou; Timothy C Tan; Luca Zazzeron; Robert E Tainsh; Patricio Leyton; Rosemary C Jones; Marielle Scherrer-Crosbie; Warren M Zapol
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

9.  Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension.

Authors:  Anita Umesh; Omkar Paudel; Yuan-Ning Cao; Allen C Myers; James S K Sham
Journal:  J Vasc Res       Date:  2011-08-10       Impact factor: 1.934

10.  Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.

Authors:  Maria G Frid; Min Li; Meena Gnanasekharan; Danielle L Burke; Miguel Fragoso; Derek Strassheim; Joanna L Sylman; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.